![]() |
|
![]() |
|
Systematic (IUPAC) name | |
---|---|
5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral (tablets) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Number | 143-76-0 ![]() |
ATC code | N05CA10 (WHO) |
PubChem | CID 5838 |
ChemSpider | 5632 ![]() |
UNII | 0M8A98AD9H ![]() |
KEGG | D07323 ![]() |
ChEMBL | CHEMBL268164 ![]() |
Chemical data | |
Formula | C12H16N2O3 |
Molar mass | 236.267 g/mol |
|
|
|
|
![]() ![]() |
Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a drug which is a barbiturate derivative.[1] It is primarily available in fixed-dose combination with diazepam under the brand name Reladorm (100 mg cyclobarbital + 10 mg diazepam) and is used to treat insomnia in Russia.[2]
References
- ^ Breimer, D. D.; Winten, M. A. (1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European journal of clinical pharmacology 09 (5–6): 443–450. PMID 989475.
- ^ "Russian State Register of Medicines. Registration Certificate: Reladorm (diazepam + cyclobarbital). Revised 02 Sep 2013" (in Russian). Retrieved 6 March 2016.
|